Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

PGC1α in the kidney.

Matthew R Lynch¹, Mei T Tran¹, Samir M Parikh¹

¹Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School , Boston, Massachusetts.

American Journal of Physiology. Renal Physiology

|September 22, 2017

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Placental nicotinamide adenine dinucleotide modulates the timing of labor.

Science (New York, N.Y.)·2026

Same author

A Rare Case of Seronegative anti-Glomerular Basement Membrane Disease with Pulmonary Involvement.

Rhode Island medical journal (2013)·2026

Same author

Quinolinic acid metabolism may mitigate AKI to CKD transition.

bioRxiv : the preprint server for biology·2025

Same author

Associations of Blood Mitochondrial DNA Quality and Quantity with Risk of Kidney Function Decline.

Clinical journal of the American Society of Nephrology : CJASN·2025

Same author

Discovery of a resistant cohort to acute kidney injury: insights from patients with septic shock.

Critical care (London, England)·2025

Same author

Reversible compromise of physiological resilience by accumulation of heteroplasmic mtDNA mutations.

Science (New York, N.Y.)·2025

Same journal

Blood Pressure Responses to Dietary Salt in Renin-Deficient Dahl Salt-Sensitive Rats.

American journal of physiology. Renal physiology·2026

Same journal

Cytokine Profiles in Patients with Chronic Kidney Disease and Low Sexual Function.

American journal of physiology. Renal physiology·2026

Same journal

Renovascular disease induces functionally relevant, locus-specific alterations to DNA methylation and hydroxymethylation in swine scattered tubular-like cells.

American journal of physiology. Renal physiology·2026

Same journal

Nitrite Protects Against Cardiac Surgery-Associated Acute Kidney Injury via Inflammation Suppression: Insights from a Rat Cardiopulmonary Bypass Model.

American journal of physiology. Renal physiology·2026

Same journal

Etanercept attenuates TNFα-mediated kidney injury in a rat model of brain death kidney donation.

American journal of physiology. Renal physiology·2026

Same journal

Phosphorylation of aquaporin-2 at serine 269 in urinary extracellular vesicles reflects renal vasopressin activity in rats.

American journal of physiology. Renal physiology·2026

See all related articles

Peroxisome proliferator-activated receptor γ coactivator-1alpha (PGC1α) plays a protective role in acute kidney injury (AKI) by regulating mitochondrial function. Understanding PGC1α

Area of Science:

Nephrology
Mitochondrial Biology
Molecular Endocrinology

Background:

Mitochondrial dysfunction is a key feature of acute kidney injury (AKI).
Peroxisome proliferator-activated receptor γ coactivator-1alpha (PGC1α) is a crucial regulator of mitochondrial biogenesis.
Reduced PGC1α levels are linked to diabetic kidney disease and renal fibrosis.

Purpose of the Study:

To review the current literature on the role of PGC1α in renal health.
To explore PGC1α as a therapeutic target for AKI, chronic kidney disease (CKD), and related conditions.
To identify future research directions concerning PGC1α in kidney disease.

Main Methods:

Literature review of studies investigating PGC1α in kidney physiology and pathology.

Keywords:

AKI CKD PGC1α kidney metabolism

Related Experiment Videos

Analysis of the association between PGC1α, mitochondrial function, and kidney disease progression.

Synthesis of findings to propose therapeutic strategies and future research avenues.

Main Results:

PGC1α demonstrates protective effects in various models of AKI.
PGC1α is implicated in maintaining mitochondrial health and function in the kidney.
Dysregulation of PGC1α contributes to the pathogenesis of CKD and renal fibrosis.

Conclusions:

PGC1α is a significant factor in maintaining renal health and combating kidney injury.
Targeting PGC1α offers a promising therapeutic strategy for AKI and CKD.
Further research into PGC1α modulation is warranted for novel kidney disease treatments.